- Home
- SER vs FGB Comparison
SER vs FGB Comparison
Compare SER & FGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SER
- FGB
- Stock Information
- Founded
- SER 2017
- FGB 2007
- Country
- SER United States
- FGB United States
- Employees
- SER N/A
- FGB N/A
- Industry
- SER Biotechnology: Pharmaceutical Preparations
- FGB Finance/Investors Services
- Sector
- SER Health Care
- FGB Finance
- Exchange
- SER Nasdaq
- FGB Nasdaq
- Market Cap
- SER 61.5M
- FGB 56.5M
- IPO Year
- SER 2018
- FGB N/A
- Fundamental
- Price
- SER $7.71
- FGB $4.15
- Analyst Decision
- SER
- FGB
- Analyst Count
- SER 0
- FGB 0
- Target Price
- SER N/A
- FGB N/A
- AVG Volume (30 Days)
- SER 21.6K
- FGB 53.0K
- Earning Date
- SER 08-09-2024
- FGB 01-01-0001
- Dividend Yield
- SER N/A
- FGB 8.92%
- EPS Growth
- SER N/A
- FGB N/A
- EPS
- SER N/A
- FGB N/A
- Revenue
- SER $3,172,500.00
- FGB N/A
- Revenue This Year
- SER N/A
- FGB N/A
- Revenue Next Year
- SER N/A
- FGB N/A
- P/E Ratio
- SER N/A
- FGB N/A
- Revenue Growth
- SER 2368.87
- FGB N/A
- 52 Week Low
- SER $5.85
- FGB $2.85
- 52 Week High
- SER $25.00
- FGB $3.74
- Technical
- Relative Strength Index (RSI)
- SER 57.44
- FGB 59.91
- Support Level
- SER $6.76
- FGB $4.01
- Resistance Level
- SER $8.14
- FGB $4.12
- Average True Range (ATR)
- SER 0.51
- FGB 0.04
- MACD
- SER 0.12
- FGB -0.00
- Stochastic Oscillator
- SER 79.62
- FGB 84.37
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.
About FGB First Trust Specialty Finance and Financial Opportunities Fund
First Trust Specialty Fnc & Fncl Oppor is a United States-based closed-end management investment company. The Fund's primary investment objective is to seek a high level of current income. It seeks a positive total return as a secondary objective. The Fund seeks to achieve its investment objectives by investing at least 80% of its Managed Assets in a portfolio of securities of specialty finance and other financial companies.